Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Nausea × ramosetron × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Vomiting 6 Postoperative Nausea and Vomiting 3 Neoplasms 3 Prostatic Neoplasms 1 Pain, Postoperative 1 Ovarian Neoplasms 1 Nausea 1 Myofibroma 1 Lung Neoplasms 1 Hematologic Neoplasms 1 Colonic Neoplasms 1 Agnosia 1 Adenomyosis 1

Interventions

Dexamethasone 30 Aprepitant 28 Ondansetron 22 Palonosetron 21 Granisetron 15 Olanzapine 12 Calcium Dobesilate 12 dexamethasone acetate 7 Therapeutics 7 Cyclophosphamide 7 casopitant 6 Doxorubicin 6 netupitant 4 fosaprepitant 4 dolasetron 4 dexamethasone 21-phosphate 4 Vincristine 4 Radiotherapy 4 Metoclopramide 4 Acupressure 4 Tropisetron 3 Prochlorperazine 3 Electroacupuncture 3 Dronabinol 3 peppermint oil 2 netupitant, palosentron drug combination 2 ginger extract 2 auricularum 2 Tablets 2 Sugars 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01046461 2012-02-17

RAD

Hallym University Medical Center

Phase 2 Unknown

Nausea, Neoplasms, Vomiting, Postoperative Nausea and Vomiting

Data powered by HemOnc (CC BY 4.0) Colophon ⚡